INTRODUCTION
was complaining about decreased functionality, distractibility, sadness, thoughts of suiside, aggresivity, loss of interest to his environment, forgetfulness.
He had a history of three manic and a depressive episodes which he was diagnosed as Bipolar I Disorder. No alcohol and subtance abuse was reported.
The first episode of the disorder had come into existence with the delusions of grandiosity and reference, increased self esteem, hyperactivity, flight of ideas, impulsivity, irritability, decreased need for sleep when he admitted to an outpatient psychiatry clinic 12 years ago. At that time, he was diagnosed as 'psychotic disorder' and given antipsychotics (risperidone) and anticholinergic durg (biperiden). He went on a remission period, but incompliance occured. He undergone two other manic episodes especially including impulsivity, agressive behaviors, graphomania, overtalkativeness, distractibility and irritability. He was diagnosed as 'Bipolar I Disorder' and given mood stabilizators (Lithium carbonate, sodium valproat), antipsychotics (olanzapine, risperidone), anticholinergic drug (biperiden) and he stayed in hospital three times during that manic period.
On follow up visits he showed depressive and cognitive symptoms like depressive affect, decreased energy levels, psychomotor retardation, hypersomnia, unwillingness, attention and working memory deficits, anhedonia, hopelessness, thoughts of guilt and fear about future life. And then olanzapine and biperiden were stopped. When using citalopram some hypomanic symptoms like excessive talking, decreased need for sleep, euphoric affect and sexual disfunction occured. Then aripiprazole 10 mg/day, bupropione 150 mg/day were added to the treatment and citalopram was stopped day by day. In the following days he was hospitalized, because his symptoms didn't show a decline. When he was discharged from hospital, his treatment was aripiprazole 5 mg/day, duloxetine 60 mg/day, sodium valproate 1250 mg/day. Cognitive and depressive symptoms repeated 3 months after discharging from hospital. His treatment was changed to lithium 1200 mg/day, venlafaxine 225 mg/day, quetiapine 600 mg/ day at outpatient clinic. On follow up he expressed depressive and hypomanic symptoms including dysphoric and depressive affect, anhedonia, suicidal thoughts and behaviours, thoughts of fear about future, overtalkativeness and graphomania, increased energy, irregular sleep, decreased appetide, increased immersion in projects, irritability, agressive behavior, impulsivity. Venlafaxine treatment was stopped for the reason of manic symptoms. He didn't show response to lithium carbonate therapy. So lithium carbonate treatment changed with sodium valproate.
Finally, he had been followed-up the inpatient clinic for two months in 2013 May to June. After 5 weeks treatment of sodium valproate 1250 mg/day, quetiapine 500 mg/day his depressive and manic symptoms improved well. On the other hand his cognitive symptoms like working memory, attention and learning deficit remained unchanged.
Neurological examination and electroensephalography were normal. Cranial Magnetic Resonance Imaging was compatible to the morphological features of Dandy Walker Variant. Bender Gestalt Visual Motor Sensation Scale (BGVMSS), Benton Visual Motor Memory Scale (BVMMS), Weschler Memory Scale (WMS) were applied to examine the organisity. Attention, working memory deficit and difficulty in learning were observed in WMS. BVMMS showed signs of cerebral organic pathology like significant turning mistakes and persevera- tions. All of them were compatible with a cerebral organic pathology. Young Mania Rating Scale (YMRS) performed before and after the treatment. During the treatment YMRS scores showed decrease from 26 to 13. Minnesota Multiphasic Personality Inventory (MMPI) was also administered to the patient. MMPI results were valid and showed an increase in hypocondriac and histrionic scales (Figures 1-3) .
DISCUSSION
Mental symptoms have been associated with Dandy Walker Variant in recent studies. A large variety of mental symptoms ranging from psychotic to cognitive and emotional were defined earlier. 17, 18 Although Dandy Walker Syndrome is usually detected in the early childhood, the patient did not state any neurologic symptom till 20 years.
Cerebellar vermis neurons plays a role in mood modulation. 19 Cerebellar vermis pathologies may be associated with changes of mood and behaviors. 20 In this case we diagnose Bipolar I Disorder presented with emotional, behavioral and cognitive changes with a cerebellar vermian and hemispheral atrophy and mega cysterna magna. This case may contibute to the association between cerebellar vermian pathology and behavioral, mood and cognitive changes.
Hypergraphy is an inappropriate and a permenant writing behavior. It is considered to be a compulsive activity that results from the lesions of globus pallidus and bilateral frontal lobes. 21 Hypergraphy have been reported about 8% of patients who had temporal lobe epilepsy. It is also a symptom of manic and hypomanic episodes of Bipolar Disorder. 22 In addition to these knowledges compulsive writing behavior can be observed in schizophrenia and frontotemporal dementia. 10 In light of the review of the literature, any studies couldn't be found about the association between dandy walker variant or other cerebellar malformations and hypergraphy.
Neuropsychiatric studies supports that the cognitive symptoms like language (including speech perception, lexical retrieval and working memory), temporal processing, implicit learning and memory and visual spatial attention defficits may be a result of cerebellar lesions, 23 but the role of cerebellum in the cognitive process have not been clearly known. 9 In the present case Weschler Memory Scale was applied to the patient and as a result; attention, working memory and learning deficits were observed. These findings compatible with the idea of association between cerebellar pathology and attention, learning and memory deficits. 
